nodes	percent_of_prediction	percent_of_DWPC	metapath
Articaine—SCN1A—L1CAM interactions—SCN10A—breast cancer	0.00297	0.0135	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—ARTN—breast cancer	0.00211	0.00957	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—ARTN—breast cancer	0.00203	0.00919	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—ARTN—breast cancer	0.00195	0.00886	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—NTN4—breast cancer	0.00193	0.00875	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—NTN4—breast cancer	0.00185	0.00841	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—RANBP9—breast cancer	0.00179	0.00813	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—NTN4—breast cancer	0.00179	0.0081	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—RANBP9—breast cancer	0.00172	0.00781	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—EVL—breast cancer	0.00169	0.00765	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—RANBP9—breast cancer	0.00166	0.00753	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—EVL—breast cancer	0.00162	0.00735	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—EVL—breast cancer	0.00156	0.00708	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—EPHB4—breast cancer	0.00153	0.00692	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—ARTN—breast cancer	0.00151	0.00683	CbGpPWpGaD
Articaine—SCN3A—L1CAM interactions—PAK1—breast cancer	0.00148	0.00672	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—EPHB4—breast cancer	0.00147	0.00664	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—EFNA1—breast cancer	0.00146	0.00663	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—ARTN—breast cancer	0.00145	0.00656	CbGpPWpGaD
Articaine—SCN2A—L1CAM interactions—PAK1—breast cancer	0.00142	0.00646	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—EPHB4—breast cancer	0.00141	0.00641	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—EFNA1—breast cancer	0.0014	0.00637	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—ARTN—breast cancer	0.00139	0.00632	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—NTN4—breast cancer	0.00138	0.00624	CbGpPWpGaD
Articaine—SCN1A—L1CAM interactions—PAK1—breast cancer	0.00137	0.00623	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—NRCAM—breast cancer	0.00136	0.00616	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—EFNA1—breast cancer	0.00135	0.00614	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—NTN4—breast cancer	0.00132	0.006	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—NRCAM—breast cancer	0.00131	0.00592	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—HNF4G—breast cancer	0.00128	0.0058	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—RANBP9—breast cancer	0.00128	0.0058	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—EBF1—breast cancer	0.00128	0.0058	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—NTN4—breast cancer	0.00128	0.00578	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—NRCAM—breast cancer	0.00126	0.00571	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—RANBP9—breast cancer	0.00123	0.00558	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—EBF1—breast cancer	0.00123	0.00558	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—HNF4G—breast cancer	0.00123	0.00558	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—SCN10A—breast cancer	0.00121	0.00549	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—EVL—breast cancer	0.0012	0.00546	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—HNF4G—breast cancer	0.00119	0.00538	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—RANBP9—breast cancer	0.00119	0.00538	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—EBF1—breast cancer	0.00119	0.00538	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—SCN10A—breast cancer	0.00116	0.00528	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—EVL—breast cancer	0.00116	0.00524	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—SCN10A—breast cancer	0.00112	0.00509	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—EVL—breast cancer	0.00111	0.00506	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—EPHB4—breast cancer	0.00109	0.00493	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—EPHB4—breast cancer	0.00105	0.00474	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—EFNA1—breast cancer	0.00104	0.00473	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—EPHB4—breast cancer	0.00101	0.00457	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—EFNA1—breast cancer	0.001	0.00455	CbGpPWpGaD
Articaine—SCN3A—L1CAM interactions—FGFR1—breast cancer	0.00098	0.00444	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—NRCAM—breast cancer	0.00097	0.0044	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—EFNA1—breast cancer	0.000967	0.00438	CbGpPWpGaD
Articaine—SCN2A—L1CAM interactions—FGFR1—breast cancer	0.000941	0.00427	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—NRCAM—breast cancer	0.000932	0.00423	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—ANGPTL4—breast cancer	0.000912	0.00414	CbGpPWpGaD
Articaine—SCN1A—L1CAM interactions—FGFR1—breast cancer	0.000908	0.00412	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—NRCAM—breast cancer	0.000899	0.00407	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—WNT10B—breast cancer	0.000887	0.00402	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—ANGPTL4—breast cancer	0.000876	0.00397	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—SCN10A—breast cancer	0.000865	0.00392	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—WNT10B—breast cancer	0.000852	0.00386	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—ANGPTL4—breast cancer	0.000845	0.00383	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—SCN10A—breast cancer	0.000831	0.00377	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—WNT10B—breast cancer	0.000822	0.00373	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—CFL1—breast cancer	0.000808	0.00367	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—SCN10A—breast cancer	0.000801	0.00363	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—CFL1—breast cancer	0.000777	0.00352	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—CFL1—breast cancer	0.000749	0.0034	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—CFL1—breast cancer	0.000577	0.00262	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—PAK1—breast cancer	0.00056	0.00254	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—CFL1—breast cancer	0.000554	0.00251	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—MED12—breast cancer	0.000548	0.00249	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—PAK1—breast cancer	0.000538	0.00244	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—CFL1—breast cancer	0.000534	0.00242	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—HSP90AA1—breast cancer	0.000531	0.00241	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—MED12—breast cancer	0.000527	0.00239	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—WNT1—breast cancer	0.000524	0.00238	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—NCOA3—breast cancer	0.000524	0.00238	CbGpPWpGaD
Articaine—SCN3A—L1CAM interactions—SRC—breast cancer	0.000522	0.00237	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—SLC2A2—breast cancer	0.00052	0.00236	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—PAK1—breast cancer	0.000519	0.00235	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—HSP90AA1—breast cancer	0.00051	0.00231	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—ADAM10—breast cancer	0.000509	0.00231	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—MED12—breast cancer	0.000508	0.0023	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—NCOA3—breast cancer	0.000503	0.00228	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—WNT1—breast cancer	0.000503	0.00228	CbGpPWpGaD
Articaine—SCN2A—L1CAM interactions—SRC—breast cancer	0.000501	0.00227	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—SLC2A2—breast cancer	0.0005	0.00227	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—HSP90AA1—breast cancer	0.000492	0.00223	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—ADAM10—breast cancer	0.000489	0.00222	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—NCOA3—breast cancer	0.000485	0.0022	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—WNT1—breast cancer	0.000485	0.0022	CbGpPWpGaD
Articaine—SCN1A—L1CAM interactions—SRC—breast cancer	0.000484	0.00219	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—SLC2A2—breast cancer	0.000482	0.00218	CbGpPWpGaD
Articaine—SCN3A—L1CAM interactions—MAPK3—breast cancer	0.000481	0.00218	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—ADAM10—breast cancer	0.000471	0.00214	CbGpPWpGaD
Articaine—Feeling abnormal—Mitoxantrone—breast cancer	0.000467	0.000599	CcSEcCtD
Articaine—Feeling abnormal—Irinotecan—breast cancer	0.000467	0.000599	CcSEcCtD
Articaine—Back pain—Docetaxel—breast cancer	0.000464	0.000595	CcSEcCtD
Articaine—Pruritus—Thiotepa—breast cancer	0.000464	0.000595	CcSEcCtD
Articaine—Pain—Fluorouracil—breast cancer	0.000464	0.000595	CcSEcCtD
Articaine—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000463	0.000594	CcSEcCtD
Articaine—Gastrointestinal pain—Irinotecan—breast cancer	0.000463	0.000594	CcSEcCtD
Articaine—SCN2A—L1CAM interactions—MAPK3—breast cancer	0.000462	0.0021	CbGpPWpGaD
Articaine—Oedema—Paclitaxel—breast cancer	0.000462	0.000592	CcSEcCtD
Articaine—SCN3A—Axon guidance—ABL1—breast cancer	0.00046	0.00209	CbGpPWpGaD
Articaine—Infection—Paclitaxel—breast cancer	0.000459	0.000589	CcSEcCtD
Articaine—SCN3A—L1CAM interactions—EGFR—breast cancer	0.000457	0.00207	CbGpPWpGaD
Articaine—Nausea—Goserelin—breast cancer	0.000455	0.000584	CcSEcCtD
Articaine—Dysgeusia—Capecitabine—breast cancer	0.000455	0.000583	CcSEcCtD
Articaine—Feeling abnormal—Gemcitabine—breast cancer	0.000454	0.000583	CcSEcCtD
Articaine—Shock—Paclitaxel—breast cancer	0.000454	0.000583	CcSEcCtD
Articaine—Dizziness—Vinorelbine—breast cancer	0.000454	0.000582	CcSEcCtD
Articaine—Tachycardia—Paclitaxel—breast cancer	0.000451	0.000578	CcSEcCtD
Articaine—Back pain—Capecitabine—breast cancer	0.000449	0.000576	CcSEcCtD
Articaine—Diarrhoea—Thiotepa—breast cancer	0.000449	0.000576	CcSEcCtD
Articaine—Skin disorder—Paclitaxel—breast cancer	0.000449	0.000575	CcSEcCtD
Articaine—Abdominal pain—Mitoxantrone—breast cancer	0.000448	0.000574	CcSEcCtD
Articaine—Abdominal pain—Irinotecan—breast cancer	0.000448	0.000574	CcSEcCtD
Articaine—Feeling abnormal—Fluorouracil—breast cancer	0.000447	0.000573	CcSEcCtD
Articaine—SCN1A—L1CAM interactions—MAPK3—breast cancer	0.000446	0.00202	CbGpPWpGaD
Articaine—Drowsiness—Methotrexate—breast cancer	0.000442	0.000567	CcSEcCtD
Articaine—SCN2A—Axon guidance—ABL1—breast cancer	0.000442	0.002	CbGpPWpGaD
Articaine—SCN2A—L1CAM interactions—EGFR—breast cancer	0.00044	0.00199	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—NCOA2—breast cancer	0.000437	0.00198	CbGpPWpGaD
Articaine—Vomiting—Vinorelbine—breast cancer	0.000437	0.00056	CcSEcCtD
Articaine—Dizziness—Thiotepa—breast cancer	0.000434	0.000556	CcSEcCtD
Articaine—Stomatitis—Methotrexate—breast cancer	0.000431	0.000553	CcSEcCtD
Articaine—Ill-defined disorder—Capecitabine—breast cancer	0.000431	0.000553	CcSEcCtD
Articaine—Headache—Vinorelbine—breast cancer	0.00043	0.000552	CcSEcCtD
Articaine—Syncope—Docetaxel—breast cancer	0.00043	0.000552	CcSEcCtD
Articaine—SCN1A—Axon guidance—ABL1—breast cancer	0.000426	0.00193	CbGpPWpGaD
Articaine—SCN1A—L1CAM interactions—EGFR—breast cancer	0.000424	0.00192	CbGpPWpGaD
Articaine—Palpitations—Docetaxel—breast cancer	0.000424	0.000544	CcSEcCtD
Articaine—Loss of consciousness—Docetaxel—breast cancer	0.000422	0.000541	CcSEcCtD
Articaine—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000421	0.00054	CcSEcCtD
Articaine—SCN2A—Developmental Biology—NCOA2—breast cancer	0.00042	0.0019	CbGpPWpGaD
Articaine—Malaise—Capecitabine—breast cancer	0.000419	0.000537	CcSEcCtD
Articaine—Cough—Docetaxel—breast cancer	0.000418	0.000537	CcSEcCtD
Articaine—Hypersensitivity—Mitoxantrone—breast cancer	0.000417	0.000535	CcSEcCtD
Articaine—Hypersensitivity—Irinotecan—breast cancer	0.000417	0.000535	CcSEcCtD
Articaine—Vomiting—Thiotepa—breast cancer	0.000417	0.000535	CcSEcCtD
Articaine—Syncope—Capecitabine—breast cancer	0.000416	0.000534	CcSEcCtD
Articaine—Paraesthesia—Paclitaxel—breast cancer	0.000415	0.000532	CcSEcCtD
Articaine—Drowsiness—Epirubicin—breast cancer	0.000414	0.000531	CcSEcCtD
Articaine—Headache—Thiotepa—breast cancer	0.000411	0.000527	CcSEcCtD
Articaine—Somnolence—Paclitaxel—breast cancer	0.000411	0.000527	CcSEcCtD
Articaine—Palpitations—Capecitabine—breast cancer	0.00041	0.000526	CcSEcCtD
Articaine—Myalgia—Docetaxel—breast cancer	0.000408	0.000524	CcSEcCtD
Articaine—Arthralgia—Docetaxel—breast cancer	0.000408	0.000524	CcSEcCtD
Articaine—Loss of consciousness—Capecitabine—breast cancer	0.000408	0.000524	CcSEcCtD
Articaine—Nausea—Vinorelbine—breast cancer	0.000408	0.000523	CcSEcCtD
Articaine—Dyspepsia—Paclitaxel—breast cancer	0.000406	0.000521	CcSEcCtD
Articaine—Asthenia—Irinotecan—breast cancer	0.000406	0.000521	CcSEcCtD
Articaine—Asthenia—Mitoxantrone—breast cancer	0.000406	0.000521	CcSEcCtD
Articaine—Neuropathy peripheral—Epirubicin—breast cancer	0.000406	0.000521	CcSEcCtD
Articaine—Cough—Capecitabine—breast cancer	0.000405	0.00052	CcSEcCtD
Articaine—SCN1A—Developmental Biology—NCOA2—breast cancer	0.000405	0.00184	CbGpPWpGaD
Articaine—Stomatitis—Epirubicin—breast cancer	0.000403	0.000518	CcSEcCtD
Articaine—SCN3A—Developmental Biology—PAK1—breast cancer	0.0004	0.00181	CbGpPWpGaD
Articaine—Hypersensitivity—Fluorouracil—breast cancer	0.0004	0.000513	CcSEcCtD
Articaine—Dry mouth—Docetaxel—breast cancer	0.000399	0.000512	CcSEcCtD
Articaine—Haemoglobin—Methotrexate—breast cancer	0.000399	0.000512	CcSEcCtD
Articaine—Haemorrhage—Methotrexate—breast cancer	0.000397	0.000509	CcSEcCtD
Articaine—Asthenia—Gemcitabine—breast cancer	0.000396	0.000508	CcSEcCtD
Articaine—Arthralgia—Capecitabine—breast cancer	0.000395	0.000507	CcSEcCtD
Articaine—Myalgia—Capecitabine—breast cancer	0.000395	0.000507	CcSEcCtD
Articaine—Pain—Paclitaxel—breast cancer	0.000395	0.000507	CcSEcCtD
Articaine—Constipation—Paclitaxel—breast cancer	0.000395	0.000507	CcSEcCtD
Articaine—Pharyngitis—Methotrexate—breast cancer	0.000394	0.000506	CcSEcCtD
Articaine—Oedema—Docetaxel—breast cancer	0.000391	0.000502	CcSEcCtD
Articaine—Discomfort—Capecitabine—breast cancer	0.000391	0.000501	CcSEcCtD
Articaine—Pruritus—Gemcitabine—breast cancer	0.00039	0.000501	CcSEcCtD
Articaine—Nausea—Thiotepa—breast cancer	0.000389	0.0005	CcSEcCtD
Articaine—Infection—Docetaxel—breast cancer	0.000389	0.000499	CcSEcCtD
Articaine—Diarrhoea—Irinotecan—breast cancer	0.000387	0.000497	CcSEcCtD
Articaine—Diarrhoea—Mitoxantrone—breast cancer	0.000387	0.000497	CcSEcCtD
Articaine—Dry mouth—Capecitabine—breast cancer	0.000387	0.000496	CcSEcCtD
Articaine—Shock—Docetaxel—breast cancer	0.000385	0.000494	CcSEcCtD
Articaine—SCN2A—Developmental Biology—PAK1—breast cancer	0.000384	0.00174	CbGpPWpGaD
Articaine—Pruritus—Fluorouracil—breast cancer	0.000384	0.000492	CcSEcCtD
Articaine—Drowsiness—Doxorubicin—breast cancer	0.000383	0.000491	CcSEcCtD
Articaine—Tachycardia—Docetaxel—breast cancer	0.000382	0.00049	CcSEcCtD
Articaine—Feeling abnormal—Paclitaxel—breast cancer	0.000381	0.000488	CcSEcCtD
Articaine—Skin disorder—Docetaxel—breast cancer	0.00038	0.000488	CcSEcCtD
Articaine—Oedema—Capecitabine—breast cancer	0.000379	0.000486	CcSEcCtD
Articaine—SCN3A—Developmental Biology—HSP90AA1—breast cancer	0.000379	0.00172	CbGpPWpGaD
Articaine—Gastrointestinal pain—Paclitaxel—breast cancer	0.000378	0.000484	CcSEcCtD
Articaine—Diarrhoea—Gemcitabine—breast cancer	0.000377	0.000484	CcSEcCtD
Articaine—Infection—Capecitabine—breast cancer	0.000376	0.000483	CcSEcCtD
Articaine—Neuropathy peripheral—Doxorubicin—breast cancer	0.000375	0.000482	CcSEcCtD
Articaine—Dizziness—Irinotecan—breast cancer	0.000374	0.00048	CcSEcCtD
Articaine—Haemoglobin—Epirubicin—breast cancer	0.000373	0.000479	CcSEcCtD
Articaine—Stomatitis—Doxorubicin—breast cancer	0.000373	0.000479	CcSEcCtD
Articaine—Shock—Capecitabine—breast cancer	0.000373	0.000478	CcSEcCtD
Articaine—Rhinitis—Epirubicin—breast cancer	0.000373	0.000478	CcSEcCtD
Articaine—Haemorrhage—Epirubicin—breast cancer	0.000372	0.000477	CcSEcCtD
Articaine—Diarrhoea—Fluorouracil—breast cancer	0.000371	0.000476	CcSEcCtD
Articaine—SCN1A—Developmental Biology—PAK1—breast cancer	0.00037	0.00168	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—FGFR1—breast cancer	0.00037	0.00168	CbGpPWpGaD
Articaine—Tachycardia—Capecitabine—breast cancer	0.00037	0.000474	CcSEcCtD
Articaine—Hypoaesthesia—Epirubicin—breast cancer	0.00037	0.000474	CcSEcCtD
Articaine—Pharyngitis—Epirubicin—breast cancer	0.000369	0.000473	CcSEcCtD
Articaine—SCN3A—Developmental Biology—NCOA1—breast cancer	0.000368	0.00167	CbGpPWpGaD
Articaine—Skin disorder—Capecitabine—breast cancer	0.000368	0.000472	CcSEcCtD
Articaine—Abdominal pain—Paclitaxel—breast cancer	0.000365	0.000468	CcSEcCtD
Articaine—SCN2A—Developmental Biology—HSP90AA1—breast cancer	0.000364	0.00165	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—ADAM10—breast cancer	0.000363	0.00165	CbGpPWpGaD
Articaine—Vomiting—Irinotecan—breast cancer	0.00036	0.000462	CcSEcCtD
Articaine—Vomiting—Mitoxantrone—breast cancer	0.00036	0.000462	CcSEcCtD
Articaine—Dizziness—Fluorouracil—breast cancer	0.000359	0.00046	CcSEcCtD
Articaine—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000357	0.000457	CcSEcCtD
Articaine—SCN2A—Axon guidance—FGFR1—breast cancer	0.000356	0.00161	CbGpPWpGaD
Articaine—Headache—Irinotecan—breast cancer	0.000355	0.000455	CcSEcCtD
Articaine—Headache—Mitoxantrone—breast cancer	0.000355	0.000455	CcSEcCtD
Articaine—SCN2A—Developmental Biology—NCOA1—breast cancer	0.000354	0.0016	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—FGF10—breast cancer	0.000353	0.0016	CbGpPWpGaD
Articaine—Paraesthesia—Docetaxel—breast cancer	0.000351	0.000451	CcSEcCtD
Articaine—SCN1A—Developmental Biology—HSP90AA1—breast cancer	0.000351	0.00159	CbGpPWpGaD
Articaine—Vomiting—Gemcitabine—breast cancer	0.000351	0.00045	CcSEcCtD
Articaine—SCN2A—Developmental Biology—ADAM10—breast cancer	0.000349	0.00158	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—KDR—breast cancer	0.000349	0.00158	CbGpPWpGaD
Articaine—Somnolence—Docetaxel—breast cancer	0.000348	0.000446	CcSEcCtD
Articaine—Haemoglobin—Doxorubicin—breast cancer	0.000346	0.000443	CcSEcCtD
Articaine—Headache—Gemcitabine—breast cancer	0.000346	0.000443	CcSEcCtD
Articaine—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000345	0.000443	CcSEcCtD
Articaine—Vomiting—Fluorouracil—breast cancer	0.000345	0.000442	CcSEcCtD
Articaine—Rhinitis—Doxorubicin—breast cancer	0.000345	0.000442	CcSEcCtD
Articaine—Dyspepsia—Docetaxel—breast cancer	0.000345	0.000442	CcSEcCtD
Articaine—Haemorrhage—Doxorubicin—breast cancer	0.000344	0.000441	CcSEcCtD
Articaine—SCN1A—Axon guidance—FGFR1—breast cancer	0.000343	0.00156	CbGpPWpGaD
Articaine—Hypoaesthesia—Doxorubicin—breast cancer	0.000342	0.000439	CcSEcCtD
Articaine—SCN1A—Developmental Biology—NCOA1—breast cancer	0.000341	0.00155	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—MET—breast cancer	0.000341	0.00155	CbGpPWpGaD
Articaine—Pharyngitis—Doxorubicin—breast cancer	0.000341	0.000438	CcSEcCtD
Articaine—Paraesthesia—Capecitabine—breast cancer	0.00034	0.000437	CcSEcCtD
Articaine—Hypersensitivity—Paclitaxel—breast cancer	0.00034	0.000436	CcSEcCtD
Articaine—Headache—Fluorouracil—breast cancer	0.00034	0.000436	CcSEcCtD
Articaine—SCN2A—Developmental Biology—FGF10—breast cancer	0.000339	0.00154	CbGpPWpGaD
Articaine—Dysgeusia—Methotrexate—breast cancer	0.000338	0.000434	CcSEcCtD
Articaine—SCN1A—Developmental Biology—ADAM10—breast cancer	0.000336	0.00153	CbGpPWpGaD
Articaine—Nausea—Mitoxantrone—breast cancer	0.000336	0.000431	CcSEcCtD
Articaine—Nausea—Irinotecan—breast cancer	0.000336	0.000431	CcSEcCtD
Articaine—SCN2A—Axon guidance—KDR—breast cancer	0.000335	0.00152	CbGpPWpGaD
Articaine—Pain—Docetaxel—breast cancer	0.000335	0.000429	CcSEcCtD
Articaine—Constipation—Docetaxel—breast cancer	0.000335	0.000429	CcSEcCtD
Articaine—Back pain—Methotrexate—breast cancer	0.000334	0.000429	CcSEcCtD
Articaine—Dyspepsia—Capecitabine—breast cancer	0.000334	0.000428	CcSEcCtD
Articaine—Asthenia—Paclitaxel—breast cancer	0.000331	0.000425	CcSEcCtD
Articaine—SCN3A—Developmental Biology—ABL1—breast cancer	0.000328	0.00149	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—MET—breast cancer	0.000328	0.00149	CbGpPWpGaD
Articaine—Nausea—Gemcitabine—breast cancer	0.000328	0.00042	CcSEcCtD
Articaine—SCN1A—Developmental Biology—FGF10—breast cancer	0.000327	0.00148	CbGpPWpGaD
Articaine—Pruritus—Paclitaxel—breast cancer	0.000327	0.000419	CcSEcCtD
Articaine—Constipation—Capecitabine—breast cancer	0.000324	0.000416	CcSEcCtD
Articaine—Pain—Capecitabine—breast cancer	0.000324	0.000416	CcSEcCtD
Articaine—SCN1A—Axon guidance—KDR—breast cancer	0.000323	0.00146	CbGpPWpGaD
Articaine—Feeling abnormal—Docetaxel—breast cancer	0.000323	0.000414	CcSEcCtD
Articaine—Nausea—Fluorouracil—breast cancer	0.000322	0.000413	CcSEcCtD
Articaine—Ill-defined disorder—Methotrexate—breast cancer	0.000321	0.000411	CcSEcCtD
Articaine—Gastrointestinal pain—Docetaxel—breast cancer	0.00032	0.000411	CcSEcCtD
Articaine—SCN3A—Developmental Biology—SMAD4—breast cancer	0.000318	0.00144	CbGpPWpGaD
Articaine—Tension—Epirubicin—breast cancer	0.000317	0.000407	CcSEcCtD
Articaine—Dysgeusia—Epirubicin—breast cancer	0.000317	0.000406	CcSEcCtD
Articaine—SCN1A—Axon guidance—MET—breast cancer	0.000316	0.00143	CbGpPWpGaD
Articaine—Diarrhoea—Paclitaxel—breast cancer	0.000316	0.000405	CcSEcCtD
Articaine—SCN2A—Developmental Biology—ABL1—breast cancer	0.000315	0.00143	CbGpPWpGaD
Articaine—Nervousness—Epirubicin—breast cancer	0.000314	0.000403	CcSEcCtD
Articaine—Back pain—Epirubicin—breast cancer	0.000313	0.000401	CcSEcCtD
Articaine—Feeling abnormal—Capecitabine—breast cancer	0.000312	0.000401	CcSEcCtD
Articaine—Malaise—Methotrexate—breast cancer	0.000312	0.0004	CcSEcCtD
Articaine—SCN3A—Developmental Biology—HES1—breast cancer	0.00031	0.00141	CbGpPWpGaD
Articaine—Gastrointestinal pain—Capecitabine—breast cancer	0.00031	0.000398	CcSEcCtD
Articaine—Abdominal pain—Docetaxel—breast cancer	0.000309	0.000397	CcSEcCtD
Articaine—SCN3A—Developmental Biology—NCOR1—breast cancer	0.000309	0.0014	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—SMAD4—breast cancer	0.000306	0.00139	CbGpPWpGaD
Articaine—Dizziness—Paclitaxel—breast cancer	0.000305	0.000392	CcSEcCtD
Articaine—SCN1A—Developmental Biology—ABL1—breast cancer	0.000304	0.00138	CbGpPWpGaD
Articaine—Cough—Methotrexate—breast cancer	0.000302	0.000387	CcSEcCtD
Articaine—Ill-defined disorder—Epirubicin—breast cancer	0.0003	0.000385	CcSEcCtD
Articaine—Abdominal pain—Capecitabine—breast cancer	0.0003	0.000384	CcSEcCtD
Articaine—SCN2A—Developmental Biology—HES1—breast cancer	0.000298	0.00135	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—NCOR1—breast cancer	0.000297	0.00134	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—SMAD4—breast cancer	0.000295	0.00134	CbGpPWpGaD
Articaine—Myalgia—Methotrexate—breast cancer	0.000294	0.000378	CcSEcCtD
Articaine—Arthralgia—Methotrexate—breast cancer	0.000294	0.000378	CcSEcCtD
Articaine—Tension—Doxorubicin—breast cancer	0.000294	0.000377	CcSEcCtD
Articaine—Vomiting—Paclitaxel—breast cancer	0.000294	0.000377	CcSEcCtD
Articaine—Dysgeusia—Doxorubicin—breast cancer	0.000293	0.000376	CcSEcCtD
Articaine—Malaise—Epirubicin—breast cancer	0.000292	0.000374	CcSEcCtD
Articaine—Discomfort—Methotrexate—breast cancer	0.000291	0.000373	CcSEcCtD
Articaine—Nervousness—Doxorubicin—breast cancer	0.000291	0.000373	CcSEcCtD
Articaine—Syncope—Epirubicin—breast cancer	0.00029	0.000372	CcSEcCtD
Articaine—Back pain—Doxorubicin—breast cancer	0.00029	0.000371	CcSEcCtD
Articaine—Headache—Paclitaxel—breast cancer	0.000289	0.000371	CcSEcCtD
Articaine—Hypersensitivity—Docetaxel—breast cancer	0.000288	0.00037	CcSEcCtD
Articaine—SCN1A—Developmental Biology—HES1—breast cancer	0.000288	0.0013	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—NCOR1—breast cancer	0.000286	0.0013	CbGpPWpGaD
Articaine—Palpitations—Epirubicin—breast cancer	0.000286	0.000367	CcSEcCtD
Articaine—SCN3A—Axon guidance—MMP2—breast cancer	0.000285	0.00129	CbGpPWpGaD
Articaine—Loss of consciousness—Epirubicin—breast cancer	0.000284	0.000365	CcSEcCtD
Articaine—Cough—Epirubicin—breast cancer	0.000282	0.000362	CcSEcCtD
Articaine—Asthenia—Docetaxel—breast cancer	0.000281	0.00036	CcSEcCtD
Articaine—Infection—Methotrexate—breast cancer	0.00028	0.00036	CcSEcCtD
Articaine—Hypersensitivity—Capecitabine—breast cancer	0.000279	0.000358	CcSEcCtD
Articaine—Ill-defined disorder—Doxorubicin—breast cancer	0.000278	0.000356	CcSEcCtD
Articaine—Pruritus—Docetaxel—breast cancer	0.000277	0.000355	CcSEcCtD
Articaine—Myalgia—Epirubicin—breast cancer	0.000275	0.000353	CcSEcCtD
Articaine—Arthralgia—Epirubicin—breast cancer	0.000275	0.000353	CcSEcCtD
Articaine—Nausea—Paclitaxel—breast cancer	0.000274	0.000352	CcSEcCtD
Articaine—Skin disorder—Methotrexate—breast cancer	0.000274	0.000352	CcSEcCtD
Articaine—SCN2A—Axon guidance—MMP2—breast cancer	0.000273	0.00124	CbGpPWpGaD
Articaine—Discomfort—Epirubicin—breast cancer	0.000272	0.000349	CcSEcCtD
Articaine—Asthenia—Capecitabine—breast cancer	0.000272	0.000349	CcSEcCtD
Articaine—Malaise—Doxorubicin—breast cancer	0.00027	0.000346	CcSEcCtD
Articaine—Dry mouth—Epirubicin—breast cancer	0.000269	0.000346	CcSEcCtD
Articaine—Syncope—Doxorubicin—breast cancer	0.000268	0.000344	CcSEcCtD
Articaine—Pruritus—Capecitabine—breast cancer	0.000268	0.000344	CcSEcCtD
Articaine—Diarrhoea—Docetaxel—breast cancer	0.000268	0.000344	CcSEcCtD
Articaine—Palpitations—Doxorubicin—breast cancer	0.000264	0.000339	CcSEcCtD
Articaine—SCN3A—Developmental Biology—FGFR1—breast cancer	0.000264	0.0012	CbGpPWpGaD
Articaine—Oedema—Epirubicin—breast cancer	0.000264	0.000339	CcSEcCtD
Articaine—SCN1A—Axon guidance—MMP2—breast cancer	0.000264	0.0012	CbGpPWpGaD
Articaine—Loss of consciousness—Doxorubicin—breast cancer	0.000263	0.000337	CcSEcCtD
Articaine—Infection—Epirubicin—breast cancer	0.000262	0.000336	CcSEcCtD
Articaine—Cough—Doxorubicin—breast cancer	0.000261	0.000335	CcSEcCtD
Articaine—Shock—Epirubicin—breast cancer	0.00026	0.000333	CcSEcCtD
Articaine—Diarrhoea—Capecitabine—breast cancer	0.000259	0.000333	CcSEcCtD
Articaine—Dizziness—Docetaxel—breast cancer	0.000259	0.000332	CcSEcCtD
Articaine—Tachycardia—Epirubicin—breast cancer	0.000258	0.000331	CcSEcCtD
Articaine—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000257	0.00033	CcSEcCtD
Articaine—Skin disorder—Epirubicin—breast cancer	0.000256	0.000329	CcSEcCtD
Articaine—Myalgia—Doxorubicin—breast cancer	0.000255	0.000327	CcSEcCtD
Articaine—Arthralgia—Doxorubicin—breast cancer	0.000255	0.000327	CcSEcCtD
Articaine—SCN3A—Developmental Biology—LEP—breast cancer	0.000254	0.00115	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—FGFR1—breast cancer	0.000254	0.00115	CbGpPWpGaD
Articaine—Paraesthesia—Methotrexate—breast cancer	0.000253	0.000325	CcSEcCtD
Articaine—SCN3A—Axon guidance—RAF1—breast cancer	0.000252	0.00114	CbGpPWpGaD
Articaine—Discomfort—Doxorubicin—breast cancer	0.000252	0.000323	CcSEcCtD
Articaine—Somnolence—Methotrexate—breast cancer	0.000251	0.000322	CcSEcCtD
Articaine—Dizziness—Capecitabine—breast cancer	0.000251	0.000321	CcSEcCtD
Articaine—SCN3A—Axon guidance—ERBB2—breast cancer	0.000249	0.00113	CbGpPWpGaD
Articaine—Dry mouth—Doxorubicin—breast cancer	0.000249	0.00032	CcSEcCtD
Articaine—Vomiting—Docetaxel—breast cancer	0.000249	0.000319	CcSEcCtD
Articaine—SCN3A—Developmental Biology—KDR—breast cancer	0.000249	0.00113	CbGpPWpGaD
Articaine—Dyspepsia—Methotrexate—breast cancer	0.000248	0.000319	CcSEcCtD
Articaine—Headache—Docetaxel—breast cancer	0.000245	0.000315	CcSEcCtD
Articaine—SCN1A—Developmental Biology—FGFR1—breast cancer	0.000245	0.00111	CbGpPWpGaD
Articaine—Oedema—Doxorubicin—breast cancer	0.000244	0.000313	CcSEcCtD
Articaine—SCN2A—Developmental Biology—LEP—breast cancer	0.000244	0.00111	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—CDK4—breast cancer	0.000244	0.0011	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—MET—breast cancer	0.000244	0.0011	CbGpPWpGaD
Articaine—Infection—Doxorubicin—breast cancer	0.000243	0.000311	CcSEcCtD
Articaine—SCN2A—Axon guidance—RAF1—breast cancer	0.000242	0.0011	CbGpPWpGaD
Articaine—Pain—Methotrexate—breast cancer	0.000241	0.000309	CcSEcCtD
Articaine—Vomiting—Capecitabine—breast cancer	0.000241	0.000309	CcSEcCtD
Articaine—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000241	0.000309	CcSEcCtD
Articaine—Shock—Doxorubicin—breast cancer	0.00024	0.000308	CcSEcCtD
Articaine—SCN2A—Axon guidance—ERBB2—breast cancer	0.00024	0.00109	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—KDR—breast cancer	0.000239	0.00108	CbGpPWpGaD
Articaine—Tachycardia—Doxorubicin—breast cancer	0.000238	0.000306	CcSEcCtD
Articaine—Headache—Capecitabine—breast cancer	0.000237	0.000305	CcSEcCtD
Articaine—Skin disorder—Doxorubicin—breast cancer	0.000237	0.000304	CcSEcCtD
Articaine—Paraesthesia—Epirubicin—breast cancer	0.000237	0.000304	CcSEcCtD
Articaine—SCN1A—Developmental Biology—LEP—breast cancer	0.000235	0.00107	CbGpPWpGaD
Articaine—Somnolence—Epirubicin—breast cancer	0.000235	0.000301	CcSEcCtD
Articaine—SCN3A—Developmental Biology—NOTCH1—breast cancer	0.000234	0.00106	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—MET—breast cancer	0.000234	0.00106	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—CDK4—breast cancer	0.000234	0.00106	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—RAF1—breast cancer	0.000234	0.00106	CbGpPWpGaD
Articaine—Nausea—Docetaxel—breast cancer	0.000232	0.000298	CcSEcCtD
Articaine—Feeling abnormal—Methotrexate—breast cancer	0.000232	0.000298	CcSEcCtD
Articaine—Dyspepsia—Epirubicin—breast cancer	0.000232	0.000298	CcSEcCtD
Articaine—SCN1A—Axon guidance—ERBB2—breast cancer	0.000231	0.00105	CbGpPWpGaD
Articaine—Gastrointestinal pain—Methotrexate—breast cancer	0.000231	0.000296	CcSEcCtD
Articaine—SCN1A—Developmental Biology—KDR—breast cancer	0.000231	0.00105	CbGpPWpGaD
Articaine—Pain—Epirubicin—breast cancer	0.000226	0.00029	CcSEcCtD
Articaine—Constipation—Epirubicin—breast cancer	0.000226	0.00029	CcSEcCtD
Articaine—SCN1A—Developmental Biology—CDK4—breast cancer	0.000226	0.00102	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—MET—breast cancer	0.000226	0.00102	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—NOTCH1—breast cancer	0.000225	0.00102	CbGpPWpGaD
Articaine—Nausea—Capecitabine—breast cancer	0.000225	0.000289	CcSEcCtD
Articaine—Abdominal pain—Methotrexate—breast cancer	0.000223	0.000286	CcSEcCtD
Articaine—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000223	0.000286	CcSEcCtD
Articaine—Paraesthesia—Doxorubicin—breast cancer	0.000219	0.000281	CcSEcCtD
Articaine—Feeling abnormal—Epirubicin—breast cancer	0.000218	0.000279	CcSEcCtD
Articaine—SCN1A—Developmental Biology—NOTCH1—breast cancer	0.000217	0.000985	CbGpPWpGaD
Articaine—Somnolence—Doxorubicin—breast cancer	0.000217	0.000279	CcSEcCtD
Articaine—Gastrointestinal pain—Epirubicin—breast cancer	0.000216	0.000277	CcSEcCtD
Articaine—Dyspepsia—Doxorubicin—breast cancer	0.000215	0.000276	CcSEcCtD
Articaine—SCN3A—Axon guidance—MMP9—breast cancer	0.000214	0.00097	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—AKT2—breast cancer	0.00021	0.000951	CbGpPWpGaD
Articaine—Constipation—Doxorubicin—breast cancer	0.000209	0.000268	CcSEcCtD
Articaine—Pain—Doxorubicin—breast cancer	0.000209	0.000268	CcSEcCtD
Articaine—Abdominal pain—Epirubicin—breast cancer	0.000209	0.000268	CcSEcCtD
Articaine—Hypersensitivity—Methotrexate—breast cancer	0.000208	0.000267	CcSEcCtD
Articaine—SCN2A—Axon guidance—MMP9—breast cancer	0.000206	0.000932	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—MMP2—breast cancer	0.000203	0.000921	CbGpPWpGaD
Articaine—Asthenia—Methotrexate—breast cancer	0.000202	0.00026	CcSEcCtD
Articaine—SCN2A—Developmental Biology—AKT2—breast cancer	0.000202	0.000914	CbGpPWpGaD
Articaine—Feeling abnormal—Doxorubicin—breast cancer	0.000201	0.000258	CcSEcCtD
Articaine—Gastrointestinal pain—Doxorubicin—breast cancer	0.0002	0.000256	CcSEcCtD
Articaine—Pruritus—Methotrexate—breast cancer	0.0002	0.000256	CcSEcCtD
Articaine—SCN1A—Axon guidance—MMP9—breast cancer	0.000198	0.000899	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—SRC—breast cancer	0.000197	0.000894	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—MMP2—breast cancer	0.000195	0.000885	CbGpPWpGaD
Articaine—Hypersensitivity—Epirubicin—breast cancer	0.000195	0.00025	CcSEcCtD
Articaine—SCN1A—Developmental Biology—AKT2—breast cancer	0.000194	0.000881	CbGpPWpGaD
Articaine—Abdominal pain—Doxorubicin—breast cancer	0.000193	0.000248	CcSEcCtD
Articaine—Diarrhoea—Methotrexate—breast cancer	0.000193	0.000248	CcSEcCtD
Articaine—SCN3A—Axon guidance—VEGFA—breast cancer	0.000192	0.000871	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—SRC—breast cancer	0.00019	0.000859	CbGpPWpGaD
Articaine—Asthenia—Epirubicin—breast cancer	0.000189	0.000243	CcSEcCtD
Articaine—SCN1A—Developmental Biology—MMP2—breast cancer	0.000188	0.000853	CbGpPWpGaD
Articaine—Pruritus—Epirubicin—breast cancer	0.000187	0.00024	CcSEcCtD
Articaine—Dizziness—Methotrexate—breast cancer	0.000187	0.000239	CcSEcCtD
Articaine—SCN2A—Axon guidance—VEGFA—breast cancer	0.000185	0.000837	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—SRC—breast cancer	0.000183	0.000829	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—MAPK3—breast cancer	0.000182	0.000824	CbGpPWpGaD
Articaine—Diarrhoea—Epirubicin—breast cancer	0.000181	0.000232	CcSEcCtD
Articaine—Hypersensitivity—Doxorubicin—breast cancer	0.00018	0.000231	CcSEcCtD
Articaine—SCN3A—Developmental Biology—RAF1—breast cancer	0.00018	0.000816	CbGpPWpGaD
Articaine—Vomiting—Methotrexate—breast cancer	0.000179	0.00023	CcSEcCtD
Articaine—SCN3A—Developmental Biology—RELA—breast cancer	0.000179	0.000812	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—ERBB2—breast cancer	0.000178	0.000807	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—VEGFA—breast cancer	0.000178	0.000807	CbGpPWpGaD
Articaine—Headache—Methotrexate—breast cancer	0.000177	0.000227	CcSEcCtD
Articaine—Asthenia—Doxorubicin—breast cancer	0.000175	0.000225	CcSEcCtD
Articaine—SCN2A—Axon guidance—MAPK3—breast cancer	0.000175	0.000792	CbGpPWpGaD
Articaine—Dizziness—Epirubicin—breast cancer	0.000175	0.000224	CcSEcCtD
Articaine—SCN3A—Axon guidance—EGFR—breast cancer	0.000173	0.000784	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—RAF1—breast cancer	0.000173	0.000784	CbGpPWpGaD
Articaine—Pruritus—Doxorubicin—breast cancer	0.000173	0.000222	CcSEcCtD
Articaine—SCN2A—Developmental Biology—RELA—breast cancer	0.000172	0.00078	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—ERBB2—breast cancer	0.000171	0.000775	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—MAPK3—breast cancer	0.000168	0.000763	CbGpPWpGaD
Articaine—Vomiting—Epirubicin—breast cancer	0.000168	0.000215	CcSEcCtD
Articaine—Nausea—Methotrexate—breast cancer	0.000168	0.000215	CcSEcCtD
Articaine—Diarrhoea—Doxorubicin—breast cancer	0.000167	0.000214	CcSEcCtD
Articaine—SCN1A—Developmental Biology—RAF1—breast cancer	0.000167	0.000756	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—EGFR—breast cancer	0.000166	0.000753	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—RELA—breast cancer	0.000166	0.000752	CbGpPWpGaD
Articaine—Headache—Epirubicin—breast cancer	0.000165	0.000212	CcSEcCtD
Articaine—SCN1A—Developmental Biology—ERBB2—breast cancer	0.000165	0.000748	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—KRAS—breast cancer	0.000163	0.000741	CbGpPWpGaD
Articaine—Dizziness—Doxorubicin—breast cancer	0.000162	0.000207	CcSEcCtD
Articaine—SCN1A—Axon guidance—EGFR—breast cancer	0.00016	0.000726	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—KRAS—breast cancer	0.000157	0.000712	CbGpPWpGaD
Articaine—Nausea—Epirubicin—breast cancer	0.000157	0.000201	CcSEcCtD
Articaine—SCN3A—Developmental Biology—CTNNB1—breast cancer	0.000156	0.000706	CbGpPWpGaD
Articaine—Vomiting—Doxorubicin—breast cancer	0.000155	0.000199	CcSEcCtD
Articaine—Headache—Doxorubicin—breast cancer	0.000153	0.000196	CcSEcCtD
Articaine—SCN3A—Developmental Biology—MMP9—breast cancer	0.000153	0.000692	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—KRAS—breast cancer	0.000151	0.000686	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—CTNNB1—breast cancer	0.00015	0.000678	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—MMP9—breast cancer	0.000147	0.000665	CbGpPWpGaD
Articaine—Nausea—Doxorubicin—breast cancer	0.000145	0.000186	CcSEcCtD
Articaine—SCN1A—Developmental Biology—CTNNB1—breast cancer	0.000144	0.000654	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—MMP9—breast cancer	0.000141	0.000641	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—SRC—breast cancer	0.000141	0.000638	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—HRAS—breast cancer	0.000139	0.000629	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—VEGFA—breast cancer	0.000137	0.000622	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—STAT3—breast cancer	0.000136	0.000616	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—SRC—breast cancer	0.000135	0.000613	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—HRAS—breast cancer	0.000133	0.000605	CbGpPWpGaD
Articaine—SCN3A—Axon guidance—IL6—breast cancer	0.000133	0.000602	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—VEGFA—breast cancer	0.000132	0.000597	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—STAT3—breast cancer	0.00013	0.000591	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—SRC—breast cancer	0.00013	0.000591	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—MAPK3—breast cancer	0.00013	0.000588	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—HRAS—breast cancer	0.000129	0.000583	CbGpPWpGaD
Articaine—SCN2A—Axon guidance—IL6—breast cancer	0.000128	0.000579	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—VEGFA—breast cancer	0.000127	0.000576	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—TGFB1—breast cancer	0.000126	0.000571	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—STAT3—breast cancer	0.000126	0.00057	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—MAPK3—breast cancer	0.000125	0.000565	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—EGFR—breast cancer	0.000123	0.000559	CbGpPWpGaD
Articaine—SCN1A—Axon guidance—IL6—breast cancer	0.000123	0.000558	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—TGFB1—breast cancer	0.000121	0.000548	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—MAPK3—breast cancer	0.00012	0.000545	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—EGFR—breast cancer	0.000119	0.000537	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—TNF—breast cancer	0.000117	0.000533	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—TGFB1—breast cancer	0.000117	0.000529	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—KRAS—breast cancer	0.000117	0.000528	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—EGFR—breast cancer	0.000114	0.000518	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—TNF—breast cancer	0.000113	0.000512	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—KRAS—breast cancer	0.000112	0.000508	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—TNF—breast cancer	0.000109	0.000494	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—KRAS—breast cancer	0.000108	0.00049	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—HRAS—breast cancer	9.91e-05	0.000449	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—HRAS—breast cancer	9.52e-05	0.000432	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—IL6—breast cancer	9.48e-05	0.00043	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—HRAS—breast cancer	9.18e-05	0.000416	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—IL6—breast cancer	9.11e-05	0.000413	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—IL6—breast cancer	8.78e-05	0.000398	CbGpPWpGaD
Articaine—SCN3A—Developmental Biology—AKT1—breast cancer	8.75e-05	0.000397	CbGpPWpGaD
Articaine—SCN2A—Developmental Biology—AKT1—breast cancer	8.4e-05	0.000381	CbGpPWpGaD
Articaine—SCN1A—Developmental Biology—AKT1—breast cancer	8.1e-05	0.000367	CbGpPWpGaD
